Article
Minneapolis, MN-Wintec International Japan Inc. and Optical Ventures Inc. (OVI) will license Vision-Ease Lens Inc.'s technology to manufacture polycarbonate polarized lenses.
Greek researchers report rare case of fungal endophthalmitis
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Inflammasome Therapeutics expands K8 trial following positive 3-month results
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Outlook Therapeutics completes analysis of 12-week safety and efficacy results of NORSE EIGHT
City Therapeutics and Bausch + Lomb partner on geographic atrophy treatment candidate